WASHINGTON, D.C. - Five plaintiffs on April 26 moved to create a multidistrict litigation for federal lawsuits in which plaintiffs claim that Pfizer Inc.'s Lipitor cholesterol drug caused them to develop diabetes (In Re: Lipitor $(Atorvastatin$) Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 2459, JPMDL)....(read more)![]()
↧